跳至主要内容
临床试验/NL-OMON52310
NL-OMON52310
招募中
不适用

Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the Avenir Complete* Femoral Stem (Implants and Instrumentation) - Avenir Complete PMCF

Zimmer Biomet Nederland bv0 个研究点目标入组 30 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
arthritis
发起方
Zimmer Biomet Nederland bv
入组人数
30
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Interventional

研究者

发起方
Zimmer Biomet Nederland bv

入排标准

入选标准

  • \- Patient is at least 20 years old or older and skeletally mature.
  • \- Patient is capable of understanding the surgeon\*s explanations and following
  • his instructions, able and willing to participate in the follow\-up program and
  • who gave consent to take part in the study;
  • \- Patient qualifies for total hip arthroplasty based on physical exam and
  • medical history including at least one of the following:
  • o Advanced wear of the joint due to degenerative, post\-traumatic or rheumatic
  • o Failed previous hip surgery including:
  • \* joint reconstruction (osteotomy)
  • \* Arthrodesis

排除标准

  • \- Acute, chronic, local, or systemic infections;
  • \- Severe muscular, neural, or vascular diseases that endanger the limbs
  • \- Lack of bony structures proximal or distal to the joint, so that good
  • anchorage of the implant is unlikely or impossible;
  • \- Total or partial absence of the muscular or ligamentous apparatus;
  • \- Any concomitant diseases that can jeopardize the functioning and the success
  • of the implant;
  • \- Allergy to the implanted material, especially to metal (e.g. cobalt,
  • chromium, etc.);

结局指标

主要结局

未指定

相似试验